Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Untch

Showing results (11-20 of 377) with videos related to

Pageof 38
Sort By:
Breast Care (Basel, Switzerland)|September 18, 2010
Lapatinib - Member of a New Generation of ErbB-Targeting DrugsMichael Untch, Hans-Joachim Lück
Breast Cancer Research : BCR|April 7, 2009
Recent advances in systemic therapy: advances in neoadjuvant (primary) systemic therapy with cytotoxic agentsMichael Untch, Gunter von Minckwitz
Breast Care (Basel, Switzerland)|December 17, 2010
Antibodies and Tyrosine Kinase Inhibitors in Breast Cancer TherapiesJ Barth, Christian Jackisch, Michael Untch
Oncology Research and Treatment|April 1, 2016
Intrinsic Subtypes of Primary Breast Cancer--Gene Expression AnalysisMarcus Schmidt, Christoph Thomssen, Michael Untch
Expert Review of Anticancer Therapy|June 25, 2003
Immunotherapy: new options in breast cancer treatmentMichael Untch, Nina Ditsch, Kerstin Hermelink
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|October 19, 2006
What is new in breast cancer? The expanding role of aromatase inhibitorsTimo Hakulinen, Michael Untch, Richard Farmer, et al.
Breast Care (Basel, Switzerland)|April 2, 2020
Concerning Dediu M, Zielinski A: A Proposal to Redefine Pathologic Complete Remission as Endpoint following Neoadjuvant Chemotherapy in Early Breast Cancer. Breast Care 2019; Doi 10.1159/000500620Michael Untch, Sibylle Loibl, Peter A Fasching
Breast (Edinburgh, Scotland)|January 17, 2013
Aromatase inhibitors in the treatment of elderly women with metastatic breast cancerStefan Glück, Gunter von Minckwitz, Michael Untch
Current Opinion in Obstetrics & Gynecology|December 25, 2012
Update on neoadjuvant/preoperative therapy of breast cancer: experiences from the German Breast GroupGunter von Minckwitz, Michael Untch, Sibylle Loibl
Critical Reviews in Oncology/Hematology|April 9, 2008
Breast cancer and pregnancy: challenges of chemotherapyMiriam S Lenhard, Ingo Bauerfeind, Michael Untch
Pageof 38

Showing results (11-20 of 377) with videos related to

Sort By:
Pageof 38
Breast Care (Basel, Switzerland)|September 18, 2010
Lapatinib - Member of a New Generation of ErbB-Targeting DrugsMichael Untch, Hans-Joachim Lück
Breast Cancer Research : BCR|April 7, 2009
Recent advances in systemic therapy: advances in neoadjuvant (primary) systemic therapy with cytotoxic agentsMichael Untch, Gunter von Minckwitz
Breast Care (Basel, Switzerland)|December 17, 2010
Antibodies and Tyrosine Kinase Inhibitors in Breast Cancer TherapiesJ Barth, Christian Jackisch, Michael Untch
Oncology Research and Treatment|April 1, 2016
Intrinsic Subtypes of Primary Breast Cancer--Gene Expression AnalysisMarcus Schmidt, Christoph Thomssen, Michael Untch
Expert Review of Anticancer Therapy|June 25, 2003
Immunotherapy: new options in breast cancer treatmentMichael Untch, Nina Ditsch, Kerstin Hermelink
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|October 19, 2006
What is new in breast cancer? The expanding role of aromatase inhibitorsTimo Hakulinen, Michael Untch, Richard Farmer, et al.
Breast Care (Basel, Switzerland)|April 2, 2020
Concerning Dediu M, Zielinski A: A Proposal to Redefine Pathologic Complete Remission as Endpoint following Neoadjuvant Chemotherapy in Early Breast Cancer. Breast Care 2019; Doi 10.1159/000500620Michael Untch, Sibylle Loibl, Peter A Fasching
Breast (Edinburgh, Scotland)|January 17, 2013
Aromatase inhibitors in the treatment of elderly women with metastatic breast cancerStefan Glück, Gunter von Minckwitz, Michael Untch
Current Opinion in Obstetrics & Gynecology|December 25, 2012
Update on neoadjuvant/preoperative therapy of breast cancer: experiences from the German Breast GroupGunter von Minckwitz, Michael Untch, Sibylle Loibl
Critical Reviews in Oncology/Hematology|April 9, 2008
Breast cancer and pregnancy: challenges of chemotherapyMiriam S Lenhard, Ingo Bauerfeind, Michael Untch
Pageof 38